Accueil>>Peptides>>β-Amyloid (1-42), rat

β-Amyloid (1-42), rat (Synonyms: Amyloid β-peptide (1-42) (rat/mouse))

Catalog No.GC37984

β-Amyloid (1-42), rat est un peptide 42-aa, montre un effet cytotoxique sur les tranches d'hippocampe aigu et utilisé dans la recherche de la maladie d'Alzheimer's.

Products are for research use only. Not for human use. We do not sell to patients.

β-Amyloid (1-42), rat Chemical Structure

Cas No.: 166090-74-0

Taille Prix Stock Qté
500μg
185,00 $US
En stock
1mg
297,00 $US
En stock
5mg
1 112,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

β-Amyloid (1-42), rat is a 42-aa peptide, shows cytotoxic effect on acute hippocampal slices, and used in the research of Alzheimer's disease. Amyloid-β[1]

β-Amyloid (1-42), rat shows cytotoxic effect on the hippocampal slices at 20 μM[1]. β-Amyloid (1-42), rat causes morphological changes in NGF-induced PC12 cells, induces formed cell processes to retract in differentiated cells and affect the expression of exons 2/3 in both undifferentiated and differentiated cells[2].

[1]. Mozes E, et al. A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays. Brain Res Bull. 2012 Apr 10;87(6):521-5. [2]. Lagunes T, et al. Abeta(1-42) induces abnormal alternative splicing of tau exons 2/3 in NGF-induced PC12 cells. An Acad Bras Cienc. 2014 Dec;86(4):1927-34.

Avis

Review for β-Amyloid (1-42), rat

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for β-Amyloid (1-42), rat

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.